A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc.
Novartis
Quadriga Biosciences, Inc.
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Valerio Therapeutics
Valerio Therapeutics
Children's Oncology Group
University of Chicago